Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pharmaxis Ltd ( (AU:SNT) ) has provided an update.
Syntara Limited has released its corporate governance statement for the financial year ending June 30, 2025, confirming compliance with the ASX Corporate Governance Council’s principles and recommendations. The statement, which is available on the company’s website, outlines the company’s adherence to governance practices, including board responsibilities, director checks, and executive agreements, thereby reinforcing its commitment to transparency and accountability in management.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.06 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Average Trading Volume: 7,328,631
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$42.32M
Find detailed analytics on SNT stock on TipRanks’ Stock Analysis page.